The DOI matches its Crossref record, with a small difference in title or year; 18 of the 19 references it cites were found in a registry or an index.
Global Skin Disease Morbidity and Mortality: An Update From the Global Burden of Disease Study 2013
Open accessAbstract
Importance: Disability secondary to skin conditions is substantial worldwide. The Global Burden of Disease Study 2013 includes estimates of global morbidity and mortality due to skin diseases. Objective: To measure the burden of skin diseases worldwide. Data Sources: For nonfatal estimates, data were found by literature search using PubMed and Google Scholar in English and Spanish for years 1980 through 2013 and by accessing administrative data on hospital inpatient and outpatient episodes. Data for fatal estimates were based on vital registration and verbal autopsy data. Study Selection: Skin disease data were extracted from more than 4000 sources including systematic reviews, surveys, population-based disease registries, hospital inpatient data, outpatient data, cohort studies, and autopsy data. Data metrics included incidence, prevalence, remission, duration, severity, deaths, and mortality risk. Data Extraction and Synthesis: Data were extracted by age, time period, case definitions, and other study characteristics. Data points were modeled with Bayesian meta-regression to generate estimates of morbidity and mortality metrics for skin diseases. All estimates were made with 95% uncertainty intervals. Main Outcomes and Measures: Disability-adjusted life years (DALYs), years lived with disability, and years of life lost from 15 skin conditions in 188 countries. Results: Skin conditions contributed 1.79% to the global burden of disease measured in DALYs from 306 diseases and injuries in 2013. Individual skin diseases varied in size from 0.38% of total burden for dermatitis (atopic, contact, and seborrheic dermatitis), 0.29% for acne vulgaris, 0.19% for psoriasis, 0.19% for urticaria, 0.16% for viral skin diseases, 0.15% for fungal skin diseases, 0.07% for scabies, 0.06% for malignant skin melanoma, 0.05% for pyoderma, 0.04% for cellulitis, 0.03% for keratinocyte carcinoma, 0.03% for decubitus ulcer, and 0.01% for alopecia areata. All other skin and subcutaneous diseases composed 0.12% of total DALYs. Conclusions and Relevance: Skin and subcutaneous diseases were the 18th leading cause of global DALYs in Global Burden of Disease 2013. Excluding mortality, skin diseases were the fourth leading cause of disability worldwide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While SDs are the fourth leading cause of consultations in health centres [11,12]”
In the citing paper
“In 2013, skin conditions contributed 1.79% to the total global burden of disease measured in DALYs across 306 diseases and injuries.”
From Global Burden of Skin Disease: Inequities and Innovations (2017) · cites this paper as [6]
In the citing paper
“Dermatitis (encompassing atopic, seborrheic, and contact types) resulted in the greatest burden of the skin conditions, costing 9.3 million DALYs”
From Global Burden of Skin Disease: Inequities and Innovations (2017) · cites this paper as [6]
In the citing paper
“Melanoma causes the greatest burden in resource-rich regions such as Australia and North America”
From Global Burden of Skin Disease: Inequities and Innovations (2017) · cites this paper as [6]
In the citing paper
“infectious causes of skin conditions, such as viral warts, pyoderma, cellulitis, and scabies, causing greater burden among children”
From Global Burden of Skin Disease: Inequities and Innovations (2017) · cites this paper as [6]
In the citing paper
“Persons of older age suffer disability burden from psoriasis, alopecia areata, urticaria, fungal skin diseases, and decubitus ulcers.”
From Global Burden of Skin Disease: Inequities and Innovations (2017) · cites this paper as [6]
In the citing paper
“dermatitis has the highest DALY rate in Sub-Saharan Africa”
From Global Burden of Skin Disease: Inequities and Innovations (2017) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
Self-citationVos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
Self-citationMurray, C. J. L., Barber, R. M., Foreman, K. J., Özgören, A. A., Abd-Allah, F., Abera, S. F., Aboyans, V., Abraham, J. P., Abubakar, I., Abu-Raddad, L. J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61340-x · Cited by 1,966
Measuring the global burden of disease
Murray, C. J. L., & Lopez, A. D. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1201534 · Cited by 1,818
Hay, R. J., Johns, N. E., Williams, H. C., Bolliger, I. W., Dellavalle, R. P., Margolis, D. J., Marks, R., Naldi, L., Weinstock, M. A., Wulf, S. K., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.446 · Cited by 1,706 · cited 2×
“J Eur Acad Dermatol Venereol 2007;21(5):643-9.”
Self-citationDisability weights for the Global Burden of Disease 2013 study
Salomon, J. A., Haagsma, J. A., Davis, A., de Noordhout, C. M., Polinder, S., Havelaar, A. H., Cassini, A., Devleesschauwer, B., Kretzschmar, M., Speybroeck, N., et al. (2015) · The Lancet Global Health · doi:10.1016/s2214-109x(15)00069-8 · Cited by 1,217
Self-citationGBD 2010: design, definitions, and metrics
Murray, C. J., Ezzati, M., Flaxman, A. D., Lim, S., Lozano, R., Michaud, C., Naghavi, M., Salomon, J. A., Shibuya, K., Vos, T., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61899-6 · Cited by 1,103 · cited 7×
“J Eur Acad Dermatol Venereol 2007;21(2):163-8.”
BackgroundInfluentialSelf-citationKnowledge, moral claims and the exercise of power in global health
Shiffman, J. (2014) · International Journal of Health Policy and Management · doi:10.15171/ijhpm.2014.120 · Cited by 243
Global Burden of Skin Disease as Reflected in Cochrane Database of Systematic Reviews
Karimkhani, C., Boyers, L. N., Prescott, L., Welch, V., Delamere, F. M., Nasser, M., Zaveri, A., Hay, R. J., Vos, T., Murray, C. J. L., et al. (2014) · JAMA Dermatology · doi:10.1001/jamadermatol.2014.709 · Cited by 87
Self-citation
Flagged first, then by citations
1 of the 19 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Global Burden of Disease Study 2013 Collaborators, 2015, Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013., Lancet, 386, 743, 10.1016/S0140-6736(15)60692-4 · DOI · Paper page
- Institute for Health Metrics and Evaluation, 2013, The Global Burden of Disease: Generating Evidence, Guiding Policy
- Institute for Health Metrics and Evaluation (IHME), 2016, Financing Global Health 2015: Development Assistance Steady on the Path to New Global Goals
Cited by
Sorted by citations
Items 701–741 of 741
Zhu, X., & Lv, Q. (2026) · Medicine Advances · doi:10.1002/med4.70060
Aktura, B., Ayşit, E., Catak, F. B., Kasap, E. U., Kıran, P., Saylar, B. A., Türkoğlu, Z., Özkoca, D., Caf, N., Gökalp, M. O., et al. (2026) · Healthcare · doi:10.3390/healthcare14111596
Cheng, Y., Zhou, C., Wang, P., Liu, H., & Han, Y. (2026) · Global Health & Medicine · doi:10.35772/ghm.2026.01058
Sia, R., Ng, S. Y., & Pang, Z. C. (2026) · Malaysian Journal of Dermatology · doi:10.4103/mjd.mjd_25_25
Polyphenol-based nanoparticles enhancing doxycycline efficacy for acne therapy
Wang, L., Song, J., Wang, H., Wang, T., Li, J., Cao, N., Li, Y., Gu, Z., & Jiang, X. (2026) · Journal of Materials Chemistry B · doi:10.1039/d5tb02875b
Adapting the Geriatric Medicine 5Ms Framework to Geriatric Dermatology
Perez, K. D., Hong, D., Zhong, X., Chang, A. L. S., Endo, J. O., & Butler, D. C. (2026) · Drugs & Aging · doi:10.1007/s40266-026-01309-6
Shih, Y., Hsu, C.-C., Hsu, C.-H., Kuo, P.-Y., Wang, Y.-H., Lee, W.-H., & Jung, C. (2026) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiag343
Hung, C., Liu, S., Wu, S., & Liu, F. (2026) · BMC Medical Education · doi:10.1186/s12909-026-09759-7
Kérob, D., Salah, S., Belo, S. E. D., Odeimi, J., Clavaud, C., & Demessant‐Flavigny, A. (2026) · Experimental Dermatology · doi:10.1111/exd.70308
Simran, Kukreja, V., Kour, K., & Mehta, S. (2026) · Discover Applied Sciences · doi:10.1007/s42452-026-09079-x
Burden of Neonatal Skin and Subcutaneous Diseases in Low‐Income Countries
Zhang, L., Zhu, L., & Fan, W. (2026) · Pediatric Dermatology · doi:10.1111/pde.70304
Dermatological Diseases in Indigenous Children and Adolescents in Polycrisis: A Scoping Review
Valencia‐Castaño, A. M., Vargas-Gallego, A. M., & Agudelo‐Hernández, F. (2026) · Pediatric Dermatology · doi:10.1111/pde.70308
Biziorek, J. A., Yonas, N., Tejasvi, T., & Renati, S. (2026) · doi:10.2196/preprints.106680
Skin and Soft Tissue Infections Caused by Gram-Negative Pathogens
y Miño, A. P., & Hareza, D. A. (2026) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2026.06.004
Morais, M. F., Silvestrini, A. V. P., Ramos, A. P., & Bentley, M. V. L. B. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108768
Characterization of Clinical and Genomic Architecture of Pulmonary Tropism in Metastatic Melanoma
Jadallah, R. K., Sharie, A. H. A., Al-Omari, S. O., Qasmieh, M., Nimri, R., Al-Bataineh, R., Khasawneh, M. Q., Ahmad, M., Mathew, T., El‐Elimat, T., et al. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-026-02583-6
da Silva, I. H. P., dos Santos, J. B. M., da Silva, L. M. R., Serpa, D. D. S., Bertino, R. G. B. B., & dos Reis, F. D. A. (2026) · Research Society and Development · doi:10.33448/rsd-v15i8.51511
Effect of housing insecurity on dermatological conditions among PLHIV in Kenya
Roozbehani, H. H., Boateng, M. O., Owuor, P. M., Adams, E. A., & Boateng, G. O. (2026) · AIDS Care · doi:10.1080/09540121.2026.2708490
Liu, X., Wan, P., Xu, B. D., Wang, Y., Fan, H., Chen, Z., & Deng, D. (2026) · Archives of Dermatological Research · doi:10.1007/s00403-026-04792-4
Cavalcante, M. L. D. S., PAIXÃO, M. D. S., Lima, K. F. N., do Monte, S. J. H., Pereira, E. M., Guimarães, P. P. G., Sousa, J. M. D. C. E., Ferreira, P. M. P., & Dittz, D. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05829-1
Bucay, V., George, R., Guiotto, A., Pecorelli, A., Ike, E., & Byrd, A. S. (2026) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.71103
Yang, Z., Liu, Y., & Yang, H. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004201
Chen, H., Liu, L., Xu, S., Li, Y., Ge, X., Zhu, X., Wang, H., & Ai, B. (2026) · Archives of Medical Science · doi:10.5114/aoms/224873
Celik, C., & Çelik, M. S. (2026) · Dicle Medical Journal / Dicle Tip Dergisi · doi:10.5798/dicletip.2036942
Anitua, E., Tierno, R., & Alkhraisat, M. H. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1901254
Akbik, M., Spiegel, B. R., Tran, R., Thompson, B., & Nambudiri, V. E. (2026) · Dermatology · doi:10.1159/drm/ackag021
In vitro Inhibition of Trichophyton rubrum by Cell-free Supernatants from Entomopathogenic Bacteria
Gülşen, Ş. H. (2026) · Sağlık Bilimlerinde Değer · doi:10.33631/sabd.1887657
Huang, L., Zhang, H., Han, J., Maoyuan, Z., Sun, H., Huang, Y., Li, Y., Chen, S., Ma, M., Song, T., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19101579
Explainable Multi-Modal AI for Dermatological Disease Identification
Bambarandage, M., Kulasekara, D., Gunarathne, J., Gunawardhana, N., Vidanaralage, A. J., & Thelijjagoda, S. (2026) · IEEE Control and System Graduate Research Colloquium (ICSGRC) · doi:10.1109/icsgrc69436.2026.11711000
Choi, H.-G., Park, S., Ban, K. A., Yu, W. R., & Lee, E. (2026) · Digital Health · doi:10.1177/20552076261495239
Acne: epidemiology, risk factors, pathogenesis, management and cutting-edge research
Li, Y., Li, G., Wang, L., Du, D., Li, J., Song, D., Li, T., Feng, P., Jiang, X., & Li, J. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02964-2
Skin Diseases: From Molecular Mechanisms to Novel Therapeutic Approaches—An Editorial
Zhang, Z., Gong, C., & Deng, G. (2026) · Biomedicines · doi:10.3390/biomedicines14102315
Markova, N. I., & Vorobtsova, E. S. (2026) · City Healthcare · doi:10.47619/2713-2617.zm.2026.v.7i3;54-66
Assefa, G. T., Ayele, S., Teklehaimanot, A., & Jikamo, B. (2026) · Pan African Medical Journal · doi:10.11604/pamj.2026.55.73.48922
Curman, P., Fischer, E., Golaboska, J., Harms, K., Borowik, J., Huckshold, J., Löscher, C.-E., Nadjmabadi, M., Maeda, A., Pourrahimi, K., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1951015
García, F. D. J. C., Torres, F. A., & Ramos, M. C. C. (2026) · Politicas Sociales Sectoriales · doi:10.29105/pss4.2-217
Impact of War on Scabies Outbreaks: A Cross-Sectional Study in Argo, Northern Sudan, 2024Preprint
Ahmed, A. M., Bababtoud, F. M. A., Shadoul, A. F., Mohamed, F. Y. A., ahmed, S. M., Babiker, A. A., & Mohammed, K. A. A. (2026) · Research Square · doi:10.21203/rs.3.rs-10721060/v1
Mwageni, N., van Wijk, R., Schoenmarkers, A., Masenga, J. E., Kasang, C., Mieras, L. F., & Mshana, S. E. (2026) · Dermatology Reports · doi:10.4081/dr.2026.10064
New and Emerging Infectious Diseases
ShamaeiZadeh, P., Khalfalla, T., Westby, S., & Freeman, E. E. (2026) · Dermatologic Clinics · doi:10.1016/j.det.2026.09.002
Dermatoprotective Potential of Hibiscus sabdariffa L.: A Systematic Review of Preclinical Evidence
Abimbola, O. G., BOLAWA, O. P., Sarandy, M. M., Novaes, R. D., Gonçalves, R. V., & Pelúzio, M. D. C. G. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27219473
Prevalence and spectrum of skin diseases in adults in China: a nationwide cross-sectional study
Li, J., Jin, H., Zhang, Y., 周培媚, Hu, Y., Zhang, L., Jin, G., Ding, Y., Fu, H., Wang, Y., et al. (2026) · The Lancet Public Health · doi:10.1016/s2468-2667(26)00126-x
Metadata
- Authors
- Karimkhani, C., Dellavalle, R. P., Coffeng, L. E., Flohr, C., Hay, R. J., Langan, S. M., Nsoesie, E. O., Ferrari, A. J., Erskine, H. E., Silverberg, J. I., Vos, T., & Naghavi, M.
- Affiliations
- University Hospitals Case Western Medical Center, Cleveland, Ohio
- Colorado School of Public Health (US)
- University of Washington (US)
- King's College London (GB)
- King's College Hospital (GB)
- London School of Hygiene & Tropical Medicine (GB)
- The University of Queensland (AU)
- Northwestern University (US)
- ORCID
- Venue
- JAMA Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 2017-05-01
- Volume
- 153
- Issue
- 5
- Pages
- 406
- ISSN
- 2168-6068 (ISSN-L)
- PMC
- PMC5817488
- OpenAlex
- W2594455611
- Cited by
- 742
- References
- 19
- Citations by year
- 2026: 80 · 2025: 88 · 2024: 110 · 2023: 99 · 2022: 79 · 2021: 82 · 2020: 96 · 2019: 53 · 2018: 41 · 2017: 13
- FWCI
- 63.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- JAMA Dermatology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Research Portal (King's College London) (submittedVersion, cc-by)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Funders
- Bill and Melinda Gates Foundation
- National Institute for Health and Care Research (NIHR/CS/010/014)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Infectious Diseases › Dermatological diseases and infestations
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Health and Epidemiology
- Keywords
- skin diseases, global burden of disease, disability-adjusted life years, years lived with disability, years of life lost, morbidity, mortality, atopic dermatitis, contact dermatitis, seborrheic dermatitis, acne, psoriasis, urticaria, viral skin infections, fungal skin infection, scabies, melanoma, pyoderma, cellulitis
- MeSH terms
- Global Burden of Disease, Adolescent, Adult, Aged, Aged, 80 and over, Bayes Theorem, Child, Child, Preschool, Female, Persons with Disabilities, Humans, Infant, Infant, Newborn, Male, Middle Aged, Skin Diseases, Global Health, Prevalence, Quality-Adjusted Life Years, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
